China's Wuhan says tested almost a third of residents for coronavirus since April

China's Wuhan says tested almost a third of residents for coronavirus since April
Reuters: Health
Wuhan, the original epicentre of the new coronavirus outbreak in China, has tested over 3 million residents for the pathogen since April, and will now focus its testing efforts on the rest of its 11 million population, according to state media.

Asia-Pacific drug trade thrives amid the COVID-19 pandemic

Asia-Pacific drug trade thrives amid the COVID-19 pandemic
Reuters: Health
Illicit drug markets in the Asia-Pacific continue to expand and diversify and appear to be largely unaffected by the coronavirus outbreak, the United Nations said on Friday.

Germany's confirmed coronavirus cases rise by 913 to 173,152: RKI

Germany's confirmed coronavirus cases rise by 913 to 173,152: RKI
Reuters: Health
The number of confirmed coronavirus cases in Germany increased by 913 to 173,152, data from the Robert Koch Institute (RKI) for infectious diseases showed on Friday.

Coronavirus: Second-highest spike in new cases as Maharashtra, Delhi numbers soar

Coronavirus: Second-highest spike in new cases as Maharashtra, Delhi numbers soar Total of 3,500 cases were added to India's Covid count. The infection continues to spiral in several states, led by Maharashtra, which again reported 1,602 cases. https://ift.tt/eA8V8J

Brazil and Mexico report record surge in coronavirus cases as Latin America reels

Brazil and Mexico report record surge in coronavirus cases as Latin America reels
Reuters: Health
Brazil and Mexico on Thursday reported a record one-day rise in new coronavirus cases, just as leaders of both countries intensified attempts to reopen their economies even as the spread of the virus in Latin America is seemingly gathering pace.

U.S. regulator is reviewing Abbott's fast COVID test after studies raise accuracy concerns

U.S. regulator is reviewing Abbott's fast COVID test after studies raise accuracy concerns
Reuters: Health
The U.S. Food and Drug Administration said on Thursday that Abbott Laboratories’ speedy coronavirus test, which can deliver results within minutes and is used at the White House, could potentially be inaccurate but can still be used to test patients.

A tale of two Japanese drugs in tests to fight COVID-19

A tale of two Japanese drugs in tests to fight COVID-19
Reuters: Health
(This May 13 story corrects to remove reference to University of Kentucky trial in penultimate paragraph)